Because the PI3K-Akt pathway plays a crucial role in tumor progression, the identification of the mechanisms by which TGF-β can modulate these pathways may provide new therapeutic targets in cancer treatment [43, 46]. The gene discussed is TGFB1; the disease is cancer.